Immunome (IMNM) Treasury Shares (2019 - 2023)

Immunome (IMNM) posted Treasury Shares of $20834.0 for Q1 2023, down 99.63% on a QoQ basis from $5.7 million in Q3 2020.

Immunome (IMNM) Treasury Shares (2019 - 2023) Analysis & Trends

Immunome's Treasury Shares history runs 3 years deep, the most recent figure standing at $20834.0 for Q1 2023.

Quarterly Treasury Shares changed N/A year-over-year to $20834.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $20834.0 (changed N/A YoY) and the FY2019 annual result came in at $4.4 million, changed N/A from the prior year.
Treasury Shares was $20834.0 for Q1 2023 at Immunome, down from $5.7 million in the prior quarter.
Across five years, Treasury Shares topped out at $5.7 million in Q2 2020 and bottomed at $20834.0 in Q1 2023.
A 3-year average of $3.9 million and a median of $4.4 million in 2019 frame the typical range for Treasury Shares.
Peak annual rise in Treasury Shares reached 82.39% in 2020, while the deepest fall reached 82.39% in 2020.
Immunome's Treasury Shares stood at $4.4 million in 2019, then advanced by 27.61% to $5.7 million in 2020, then plunged by 99.63% to $20834.0 in 2023.
Business Quant data shows IMNM's Treasury Shares at $20834.0 in Q1 2023, $5.7 million in Q3 2020, and $5.7 million in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-21,709.08
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	265,401.92
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	19.41 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	5.14 Mn
10	Immunome	2.49 Bn	1.91 Bn	-	-

Download Data